Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FWD1509 MsOH in Advanced NSCLC
NCT05068024Phase 2Recruiting
- Start
- Aug 2021
- Primary completion
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fwd1509 in non-small cell lung cancer (NSCLC). Started Aug 2021; status: recruiting.
02
Drugs
fwd1509
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT05068024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05068024.